New pH-responsive gemini lipid derived co-liposomes for efficacious doxorubicin delivery to drug resistant cancer cells
journal contribution
posted on 2017-07-25, 00:00 authored by P Moitra, K Kumar, S Sarkar, P Kondaiah, Wei DuanWei Duan, S BhattacharyaA new pH-sensitive co-liposomal formulation was developed which could efficiently transport doxorubicin across the DOX-resistant cancer cells.
History
Journal
Chemical CommunicationsVolume
53Pagination
8184-8187Location
EnglandISSN
1359-7345eISSN
1364-548XLanguage
EnglishPublication classification
C Journal article, C1 Refereed article in a scholarly journalCopyright notice
2017, The Royal Society of ChemistryIssue
58Publisher
ROYAL SOC CHEMISTRYUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyPhysical SciencesChemistry, MultidisciplinaryChemistryCATIONIC LIPIDSVESICLE FORMATIONSENSITIVE IMMUNOLIPOSOMESMOLECULAR DESIGNGENE DELIVERYPLASMID DNAACIDRELEASESERUMNANOPARTICLESgemini versionpalmitoyl homocysteineCo-liposomesanticancer drugdoxorubicin (DOX)HeLa cancer cellscellular endosomes111299 Oncology and Carcinogenesis not elsewhere classified3211 Oncology and carcinogenesis
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC